Document is current
Any future updates will be listed below
-
Authors
Nederlof, I. https://orcid.org/0000-0001-7608-6515
Hajizadeh, S.
Sobhani, F. https://orcid.org/0000-0002-1787-4455
Raza, S. E. A. https://orcid.org/0000-0002-1097-1738
AbdulJabbar, K. https://orcid.org/0000-0002-4411-4435
Harkes, R. https://orcid.org/0000-0001-6592-654X
van de Vijver, M. J.
Salgado, R. https://orcid.org/0000-0002-1110-3801
Desmedt, C. https://orcid.org/0000-0002-5223-5579
Kok, M.
Yuan, Y.
Horlings, H. M. https://orcid.org/0000-0003-4782-8828
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (10510, 10510, 10510, 10510)
- License Information
-
More Information
Article History
Received: 6 August 2021
Accepted: 19 March 2022
First Online: 28 April 2022
Competing interests
: I.N., S.H., F.S., K.A., and R.H. declare no conflict of interest. M.K. reports research funding to the institute from BMS, Roche, AZ outside the submitted work. M.K. is advisory board member for BMS, MSD, Daiichi, Roche. R.S. reports non-financial support from Merck and Bristol Myers Squibb; research support from Merck, Puma Biotechnology, and Roche; and advisory board fees for Bristol Myers Squibb; and personal fees from Roche for an advisory board related to a trial-research project. Y.Y. has received speakers bureau honoraria from Roche and consulted for Merck and Co Inc. H.M.H. receives research support from Roche paid to the institution outside the scope of this work and has an advisory role for SlideScore.com without any financial support. The funders had no role in the design of the study; the collection, analysis, or interpretation of the data; the writing of the manuscript; or the decision to submit the manuscript for publication.
